EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fertility Preservation in BRCA1/2 Germline Mutation Carriers: An Overview

Erica Silvestris, Gennaro Cormio iD, Vera Loizzi iD, Giacomo Corrado iD, Francesca Arezzo, Easter Anna Petracca

Life · 10.05.2024 · 14 (5) · 615

DOI: 10.3390/life14050615 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 10.05.2024. Verfasst von Erica Silvestris und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRCA1 and BRCA2 mutations are responsible for a higher incidence of breast and ovarian cancer (from 55% up to 70% vs. 12% in the general population). If their functions have been widely investigated in the onset of these malignancies, still little is known about their role in fertility impairment. Cancer patients treated with antineoplastic drugs can be susceptible to their gonadotoxicity and, in women, some of them can induce apoptotic program in premature ovarian follicles, progressive depletion of ovarian reserve and, consequently, cancer treatment-related infertility (CTRI). BRCA variants seem to be associated with early infertility, thus accelerating treatment impairment of ovaries and making women face the concrete possibility of an early pregnancy. In this regard, fertility preservation (FP) procedures should be discussed in oncofertility counseling—from the first line of prevention with risk-reducing salpingo-oophorectomy (RRSO) to the new experimental ovarian stem cells (OSCs) model as a new way to obtain in vitro-differentiated oocytes, several techniques may represent a valid option to BRCA-mutated patients. In this review, we revisit knowledge about BRCA involvement in lower fertility, pregnancy feasibility, and the fertility preservation (FP) options available.

Schlagwörter

Stichwörter der Autor:innen

BRCAfertility preservationoncofertilityovarian stem cellpremature ovarian failure

Autor:innen und Institutionen

  • Gynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
  • Department of Interdisciplinary Medicine (DIM), University of Bari "Aldo Moro", 70121 Bari, Italy.
  • Department of Woman, Child Health and Public Health, Gynecologic Oncology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00136 Rome, Italy.

ORCID-Profile: Gennaro Cormio, Vera Loizzi, Giacomo Corrado

Zitieren

APA

Silvestris, E., Cormio, G., Loizzi, V., Corrado, G., Arezzo, F., & Petracca, E. A. (2024). Fertility Preservation in BRCA1/2 Germline Mutation Carriers: An Overview. Life, 14(5), 615. https://doi.org/10.3390/life14050615

Vancouver

Silvestris E, Cormio G, Loizzi V, Corrado G, Arezzo F, Petracca EA. Fertility Preservation in BRCA1/2 Germline Mutation Carriers: An Overview. Life. 2024;14(5):615. doi:10.3390/life14050615

BibTeX
@article{Silvestris2024,
  author = {Silvestris, Erica and Cormio, Gennaro and Loizzi, Vera and Corrado, Giacomo and Arezzo, Francesca and Petracca, Easter Anna},
  title = {Fertility Preservation in BRCA1/2 Germline Mutation Carriers: An Overview},
  journal = {Life},
  year = {2024},
  volume = {14},
  number = {5},
  pages = {615},
  doi = {10.3390/life14050615}
}
Kostenlos starten →